Inhibition of 5α-reductase function with 5α-reductase inhibitors (5-ARIs), such as finasteride and dutasteride, impairs androgen receptor (AR) signaling via ablating DHT formation and induces apoptosis in prostate epithelial cells, which is the basis for BPH therapy5. This evidence concerns the gene AR and benign prostatic hyperplasia.